|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0036043,
umls-concept:C0078058,
umls-concept:C0087111,
umls-concept:C0205276,
umls-concept:C0205390,
umls-concept:C0264694,
umls-concept:C0302600,
umls-concept:C0333186,
umls-concept:C0439245,
umls-concept:C0595454,
umls-concept:C0812325,
umls-concept:C1151964,
umls-concept:C1171892,
umls-concept:C1274040,
umls-concept:C1517499,
umls-concept:C1547239,
umls-concept:C1708528,
umls-concept:C2828981
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
2003-6-3
|
|
pubmed:abstractText |
Catheter-based intracoronary vascular endothelial growth factor (VEGF) gene transfer is a potential treatment for coronary heart disease. However, only limited data are available about local VEGF gene transfer given during angioplasty (PTCA) and stenting.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:HartikainenJuhaJ,
pubmed-author:HedmanAnttiA,
pubmed-author:HedmanMarjaM,
pubmed-author:KauppilaEsaE,
pubmed-author:KiveläAnttiA,
pubmed-author:LaaksoMarkkuM,
pubmed-author:MussaloHannaH,
pubmed-author:NärvänenOutiO,
pubmed-author:NieminenMarkku SMS,
pubmed-author:PeuhkurinenKeijoK,
pubmed-author:RantalaArtoA,
pubmed-author:SimulaSakariS,
pubmed-author:StjernvallJoachimJ,
pubmed-author:SyvänneMikkoM,
pubmed-author:VanninenEskoE,
pubmed-author:Ylä-HerttualaSeppoS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
3
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2677-83
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12742981-Adenoviridae,
pubmed-meshheading:12742981-Adult,
pubmed-meshheading:12742981-Aged,
pubmed-meshheading:12742981-Angioplasty, Balloon, Coronary,
pubmed-meshheading:12742981-Chronic Disease,
pubmed-meshheading:12742981-Coronary Restenosis,
pubmed-meshheading:12742981-Coronary Vessels,
pubmed-meshheading:12742981-Double-Blind Method,
pubmed-meshheading:12742981-Endothelial Growth Factors,
pubmed-meshheading:12742981-Feasibility Studies,
pubmed-meshheading:12742981-Female,
pubmed-meshheading:12742981-Finland,
pubmed-meshheading:12742981-Gene Therapy,
pubmed-meshheading:12742981-Gene Transfer Techniques,
pubmed-meshheading:12742981-Heart Catheterization,
pubmed-meshheading:12742981-Humans,
pubmed-meshheading:12742981-Injections, Intra-Arterial,
pubmed-meshheading:12742981-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:12742981-Lymphokines,
pubmed-meshheading:12742981-Male,
pubmed-meshheading:12742981-Middle Aged,
pubmed-meshheading:12742981-Myocardial Ischemia,
pubmed-meshheading:12742981-Safety,
pubmed-meshheading:12742981-Stents,
pubmed-meshheading:12742981-Treatment Outcome,
pubmed-meshheading:12742981-Vascular Endothelial Growth Factor A,
pubmed-meshheading:12742981-Vascular Endothelial Growth Factors,
pubmed-meshheading:12742981-Vascular Patency
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).
|
|
pubmed:affiliation |
A.I. Virtanen Institute, University of Kuopio, PO Box 1627, FIN-70211 Kuopio, Finland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
